| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Professional Issues Articles
A study out of Beth Israel Deaconess Medical Center has found that to restore normal glucose levels in type 1 diabetic mice, it's not enough to halt the destruction of their beta cells. You also have to reverse the muscle and fat inflammation that prevents insulin from transferring glucose into those tissues.
The researchers started by giving diabetic mice a combination of three drugs that not only halted the immune destruction of their beta cells, but also relieved the inflammation in their muscle and fat tissues. They found that increasing insulin-producing beta cells and circulating insulin levels weren't enough to achieve good blood sugars.
Instead, the restoration of good blood sugars was linked to relief from the inflammatory state that impaired the mice's response to insulin. Both restoration of beta cells and relief from the inflammatory state in insulin-sensitive tissues were necessary to achieve permanent restoration of normal sugar levels.
Thus, this new triple-therapy regimen, possessing both tolerance-inducing and select anti-inflammatory properties, may represent a way to restore normal blood sugars and self-tolerance in type 1 diabetes. (The three drugs, in case you'd like to know, were rapamycin plus agonist IL-2-related and antagonist-type, mutant IL-15-related Ig fusion proteins (IL-2.Ig and mutIL-15.Ig.))
Sources: EurekAlert; Proceedings of the National Academy of Sciences, August 2007
Categories: Professional Issues, Type 1 Issues
Nov 22, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.